Cargando…
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study
INTRODUCTION: Pregnant individuals with substance use disorders face complex issues that may serve as barriers to treatment entry and retention. Several professional organizations have established recommendations on comprehensive, collaborative approaches to treatment to meet the needs of this popul...
Autores principales: | Kropp, Frankie B., Smid, Marcela C., Lofwall, Michelle R., Wachman, Elisha M., Martin, Peter R., Murphy, Sean M., Wilder, Christine M., Winhusen, T. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249488/ https://www.ncbi.nlm.nih.gov/pubmed/37023858 http://dx.doi.org/10.1016/j.josat.2023.209030 |
Ejemplares similares
-
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
por: Winhusen, Theresa, et al.
Publicado: (2020) -
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”
por: Shulman, Matisyahu, et al.
Publicado: (2021) -
Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids
por: Winhusen, Theresa, et al.
Publicado: (2020) -
A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
por: Winhusen, Theresa, et al.
Publicado: (2020) -
EHMTI-0080. How migraine is affected by therapies for multiple sclerosis
por: Condello, C, et al.
Publicado: (2014)